VistaGen Therapeutics Initiates PALISADE Phase 3 Trial of PH94B in Social Anxiety Disorder - GlobeNewswire

Submitted by Anonymous (not verified) on Wed, 05/26/2021 - 12:00

VistaGen Therapeutics Initiates PALISADE Phase 3 Trial of PH94B in Social Anxiety Disorder  GlobeNewswire